ReFlections Volume 63, October 2024

Hilary Henly
Dr. Adela Osman
Dr. Sheetal Salgaonkar
Dr. Kim-Anh Vu
Dr. Steve Woh
Dr. Daniel D. Zimmerman

Red Adirondack chair on a dock looking over a lake

In Brief

Explore in-depth articles on important medical topics and stay up to date on a range of hot-button issues impacting life and health insurers, from the health impacts of Bisphenol A (BPA) to considerations around GLP-1 drugs.

Welcome to the October 2024 issue of ReFlections. Features this month explore the evaluation and treatment of pediatric obesity and the implications for insurers as well as the link between exposure to Bisphenol A from plastic products and serious health issues.

Other highlights include:

An interview with David Sinclair, CEO of the International Longevity Centre, UK, by ReFlections co-editor Dan Zimmerman on societal challenges related to aging populations
Underwriting a challenging mammogram case
Perspectives on GLP-1 receptor agonists and summaries of recent studies on dementia prevention and care, tirzepatide for the treatment of sleep apnea and obesity, and cancer rates among US adults
Updated underwriting guidelines for asthma and Hodgkin lymphoma

View ReFlections, Volume 63

Explore the ReFlections archive

A woman in a red shirt leads a brainstorm

RGA’s market-leading medical and underwriting knowledge means we formulate ratings that provide assurance for our clients. With RGA’s Global Underwriting Manual (GUM), insurers have the power of a recognized global leader with them every step of the way.

Learn how to get started with GUM